These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 7007618)

  • 1. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y; Wada H; Yagura T; Matsushima A; Inada Y
    J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in the therapeutic, immunological, and clearance properties of Escherichia coli and Erwinia carotovora L-asparaginases by attachment of poly-DL-alanyl peptides.
    Uren JR; Ragin RC
    Cancer Res; 1979 Jun; 39(6 Pt 1):1927-33. PubMed ID: 376113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased antitumor activity of Escherichia coli. L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y; Wada H; Yagura T; Nishimura H; Matsushima A; Inada Y
    Gan; 1982 Jun; 73(3):470-4. PubMed ID: 6751921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemical modification of E. coli L-asparaginase by N,O-carboxymethyl chitosan.
    Qian G; Zhou J; Ma J; Wang D; He B
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):567-77. PubMed ID: 8922226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia.
    Yoshimoto T; Nishimura H; Saito Y; Sakurai K; Kamisaki Y; Wada H; Sako M; Tsujino G; Inada Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1264-70. PubMed ID: 3102431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gel entrapped L-asparaginase: kinetic behavior and antitumor activity.
    O'Driscoll KF; Korus RA; Ohnuma T; Walczack IM
    J Pharmacol Exp Ther; 1975 Nov; 195(2):382-8. PubMed ID: 241845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies on modified enzymes. I. soluble L-asparaginase/mouse albumin copolymer with enzyme activity and substantial loss of immunogenicity.
    Yagura T; Kamisaki Y; Wada H; Yamamura Y
    Int Arch Allergy Appl Immunol; 1981; 64(1):11-8. PubMed ID: 7450899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modification of L-asparaginase with colominic acid and the new characteristics of the modified enzyme].
    Wang YD; Guo L; Qian SJ; Meng GZ; Zhang SZ
    Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):517-20. PubMed ID: 11051832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.
    Zhang YQ; Zhou WL; Shen WD; Chen YH; Zha XM; Shirai K; Kiguchi K
    J Biotechnol; 2005 Nov; 120(3):315-26. PubMed ID: 16102867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
    Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.
    Uren JR; Hargis BJ; Beardsley P
    Cancer Res; 1982 Oct; 42(10):4068-71. PubMed ID: 7105004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation of repeatedly and effectively usable L-asparaginase by a chemical modification].
    Nishimura H; Wada H; Inada Y
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2227-35. PubMed ID: 6548355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, physicochemical and immunological properties of oxidized inulin-L-asparaginase bioconjugate.
    Tabandeh MR; Aminlari M
    J Biotechnol; 2009 May; 141(3-4):189-95. PubMed ID: 19433225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of L-asparaginase and the effects of host and enzyme modification.
    Uren JR
    Cancer Treat Rep; 1981; 65 Suppl 4():47-55. PubMed ID: 6125260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification of L-asparaginase with comb-shaped copolymer of poly(ethylene glycol) derivative and maleic anhydride.
    Saito T; Ueno T; Sekine T; Kodera Y; Hiroto M; Matsushima A; Nishimura H; Inada Y
    Leukemia; 1997 Apr; 11 Suppl 3():408-9. PubMed ID: 9209407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis and study of biospecific sorbents for isolating and purifying L-asparaginase from Escherichia coli].
    Vlasov GP; Martiushin SV; Glushenkova VR; Ditkovskaia IB
    Prikl Biokhim Mikrobiol; 1979; 15(1):74-81. PubMed ID: 95826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of L-asparagine in Tetrahymena pyriformis ecto-L-asparaginase is not related to L-asparagine-protein transport system.
    Tsavdaridis IK; Triantafillou DJ; Kyriakidis DA
    Biochem Int; 1991 May; 24(2):281-90. PubMed ID: 1930247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
    Park YK; Abuchowski A; Davis S; Davis F
    Anticancer Res; 1981; 1(6):373-6. PubMed ID: 7046623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.
    Abuchowski A; van Es T; Palczuk NC; McCoy JR; Davis FF
    Cancer Treat Rep; 1979 Jun; 63(6):1127-32. PubMed ID: 466651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilization of L-asparaginase into a biocompatible poly(ethylene glycol)-albumin hydrogel: evaluation of performance in vivo.
    Jean-François J; D'Urso EM; Fortier G
    Biotechnol Appl Biochem; 1997 Dec; 26(3):203-12. PubMed ID: 9428158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.